Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications economic impact analysis coronary heart disease attributed health care cost savings
… include: Highlights and Overview Product Information and Disease Description Clinical Evidence Economic Information PIE Decks and Other Communication Materials Sharing certain health care economic and scientific information about your …
… A Global Review of Quality-of-Life Impact A Global Review of Quality-of-Life Impact of Atopic … decreased social functioning and impaired psychological health. In fact, the quality-of-life impact is reported to be … than that caused by other chronic conditions such as renal disease, diabetes, and cystic fibrosis. We reviewed the …
… experts will be presented at ESPID 2024. Public health impact of MENABCWY vaccination in adolescents and MENB … M , Myers E, Diaz-Decaro J. Poster. Public health and economic impact of pediatric immunization program in Greece. … productivity losses associated with invasive meningococcal disease (IMD) in the United States (US). Shah H, …
… in this process is developing a comprehensive health economic outcomes research (HEOR) strategy roadmap that … Insight: Imagine you have a novel treatment for a chronic disease. Early discussions with payers might reveal a high … Cost-benefit analyses and HEOR can highlight the economic impact of your technology compared to existing treatments. …
… productivity, including applications in radiologic image analysis and natural language processing. Academic … task force to evaluate how generative AI could positively impact the lives of oncology professionals and their … outcomes assessment, epidemiology, evidence synthesis, and economic evaluation, as well as expertise in integrated …
… US costing sources, and expert opinion. We estimated cost per life-year saved and cost per QALY gained from a hospital perspective. …
… Advancements in EU Health Technology Regulation and Lowering US Medicare Costs … moves along in its development, directives regarding rare disease therapies will be introduced in January 2028. And … Clinical Assessments: Racing to the Finish Line at What Cost? Emergence of the Joint Clinical Assessment in the …
… Tailoring Cost-Effectiveness Modeling Methodologies for Multiple … and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple … Herring, PhD, discusses how to tailor real-world analysis methodologies so that they better fit the needs of …
… Real-World Comparative Effectiveness Analysis for Use in Cost-Effectiveness Modeling in Multiple Sclerosis …
… Note here that the guidance states, “In considering impact on specific populations and patients with unmet … will review real-world evidence (RWE), conduct an internal analysis, and consult with experts regarding evidence of the … drug’s value Clinical experience Health research (e.g., economic and health equity data) Types of Evidence Center for …